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Background: Drug-eluting stents (DES) rapidly dominated the marketplace shortly after introduction, but previous research has suggested the 
rates of usage was initially lower among African-American (AA) approval. To date, it is not known whether this difference persisted as DES diffused 
into practice.
Methods: Analysis of Medicare Provider Analysis and Review files from 2003 and 2004 identified coronary stenting procedures among eldery 
patients with acute coronary syndrome by using discharge diagnosis and procedure codes. Comorbidities were assigned using a modification 
of the Healthcare Cost and Utilization Project’s comorbidity software. We developed a linear probability model incorporating demographics 
(including Medicaid buy-in, zip-code level median household income, and rurality as categorized by Rural Urban Commuting Area (RUCA)), ACS type, 
comorbidies, and hospital-level fixed effects. AA race was interacted with discharge month to estimate a non-linear effect of race over time.
Results: The sample included 247,259 episodes treated with stent insertion, of which 12,700 (5.1%) involved AA patients. Compared with non-
AA patients, AA patients were younger, more likely to be female or to live in a metropolitan RUCA, lived in zip codes with lower median household 
incomes, and were more likely to be eligible for Medicaid. AA patients were less likely to present with ST-elevation myocardial infarction, had higher 
rates of congestive heart failure, diabetes, anemia, peripheral vascular disease, and renal disease, and had lower rates of chronic lung disease. In 
the model, AA race was associated with lower rates of DES usage until February 2004 (44.0% vs. 46.4%, p<0.0001), after which differences were not 
signficant (80.9% vs 81.4%, p = 0.40).
Discussion: While an effect of race independent of economic, clinical, and hospital-level factors was present after DES introduction, this disparity 
was eliminated within the first year. Further work is needed to discern how other socioecononomic factors may affect access to DES. AA patients 
comprise a relatively small proportion of patients receiving coronary stents.
